reference/28653918

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28653918

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	2710
issn	0021-9738
issueIdentifier	6
pageRange	2702-2710
publicationName	The Journal of clinical investigation
startingPage	2702
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e7cafd8ff11263870879435c0313ce75 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_feff60d32612c2deaa41846f74395b19 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_29b5136944012658da4aef9319d46ae3
bibliographicCitation	Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest. 1995 Dec;96(6):2702–10. PMID: 8675637; PMCID: PMC185977.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9c4e3cb336f4f88dc734635a4d3ade9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dba05869e1e5c0364e348496e578fcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c94ba05133f4b12587d9fb8b86021369 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef71c25bae4530d1bd79ea11d75afe1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62cb06d25308acb576c8f83f1ef9e5b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ee38ee41147698e3024995b5fe907d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64f540e4e967612ad6b8bf438a194878
date	1995-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/8675637 https://doi.org/10.1172/jci118337 https://pubmed.ncbi.nlm.nih.gov/PMC185977
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.
discusses	http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0019678 http://id.nlm.nih.gov/mesh/M0482536 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0011758 http://id.nlm.nih.gov/mesh/M0210458 http://id.nlm.nih.gov/mesh/M0221667 http://id.nlm.nih.gov/mesh/M0127894 http://id.nlm.nih.gov/mesh/M0210462
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012697Q000097 http://id.nlm.nih.gov/mesh/D007527Q000097 http://id.nlm.nih.gov/mesh/D008415Q000097 http://id.nlm.nih.gov/mesh/D008407Q000201
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D011994Q000302 http://id.nlm.nih.gov/mesh/D000911 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D053818 http://id.nlm.nih.gov/mesh/D053802 http://id.nlm.nih.gov/mesh/D008415Q000145 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D012697Q000302 http://id.nlm.nih.gov/mesh/D004591 http://id.nlm.nih.gov/mesh/D007527Q000302 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000707Q000201 http://id.nlm.nih.gov/mesh/D008415Q000201 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000707Q000097 http://id.nlm.nih.gov/mesh/D000208 http://id.nlm.nih.gov/mesh/D012016 http://id.nlm.nih.gov/mesh/D007700
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.59 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8428 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6868 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10759

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7177

Total number of triples: 69.